Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 9/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 8/20 | 0.47 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
| ▸ | FNTA | P49354 | 2/20 | 0.34 |
| ▸ | FNTB | P49356 | 2/20 | 0.34 |
| ▸ | SHBG | P04278 | 3/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8009030 | 1.00 | SRD5A1 (0.47) | SRD5A1SRD5A2GPBAR1NR1H4FNTA | |
| SCHEMBL8003369 | 0.90 | SRD5A1 (0.49) | SRD5A1SRD5A2GPBAR1NR1H4FNTA | |
| SCHEMBL8003366 | 0.90 | SRD5A1 (0.49) | SRD5A1SRD5A2GPBAR1NR1H4FNTA | |
| SCHEMBL8002701 | 0.83 | SRD5A1 (0.44) | SRD5A1SRD5A2GPBAR1NR1H4FNTA | |
| SCHEMBL8002703 | 0.83 | SRD5A1 (0.44) | SRD5A1SRD5A2GPBAR1NR1H4FNTA | |
| SCHEMBL7993713 | 0.83 | SRD5A1 (0.69) | SRD5A1SRD5A2FNTAFNTB | |
| SCHEMBL8316920 | 0.82 | SRD5A1 (0.47) | SRD5A1SRD5A2GPBAR1NR1H4FNTA | |
| SCHEMBL7993711 | 0.82 | SRD5A1 (0.47) | SRD5A1SRD5A2GPBAR1NR1H4FNTA | |
| SCHEMBL8319303 | 0.82 | SRD5A1 (0.33) | SRD5A1SRD5A2 | |
| SCHEMBL8319307 | 0.82 | SRD5A1 (0.33) | SRD5A1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0858455-A4 | 4-OXA AND 4-THIA STEROIDS | MERCK & CO INC (US) | 2000-04-12 | — | — | EP | claimed |
| EP-0858455-A1 | 4-OXA AND 4-THIA STEROIDS | Merck & Co., Inc. (US) | 1998-08-19 | — | — | EP | claimed |
| US-5777134-A | 4-oxa and 4-thia steriods | MERCK & CO., INC. (US) | 1998-07-07 | — | — | US | claimed |
| WO-1997015564-A1 | 4-OXA AND 4-THIA STEROIDS | MERCK & CO., INC. (US) | 1997-05-01 | — | — | WO | claimed |
| US-5998464-A | 4-Oxa and 4-thia steroids | MERCK & CO., INC. (US) | 1999-12-07 | — | — | US | disclosed |
| US-5932559-A | Treatment of hyperandrogenic conditions | MERCK & CO., INC. (US) | 1999-08-03 | — | — | US | disclosed |
| US-5777134-A | 4-oxa and 4-thia steriods | MERCK & CO., INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5756480-A | Treatment of hyperandrogenic conditions | MERCK & CO., INC. (US) | 1998-05-26 | — | — | US | disclosed |
| WO-1997015305-A1 | TREATMENT OF HYPERANDROGENIC CONDITIONS | MERCK & CO., INC. (US) | 1997-05-01 | — | — | WO | disclosed |